current digital currencies Top People searches

Zhu Haoxiang, the Chinese director of the US SEC, resigned. The US Securities and Exchange Commission recently announced that Zhu Haoxiang, the director of the Trading and Marketing Department, will leave on December 10, 2024, and he will return to the Si Long School of Management at MIT to continue to serve as an associate professor of finance. As one of the important members of Gary Gensler, the current chairman of the SEC, Zhu Haoxiang was appointed by the SEC in December 2021. (Caixin. com)It is predicted that the State Council Press Office will hold a press conference at 10 am on Monday, December 16th, 2024, and ask Fu Linghui, spokesperson of the National Bureau of Statistics and head of the National Economic Statistics Department, to introduce the national economic operation in November 2024 and answer questions from reporters.Beizheng 50 rose more than 1%, Huayang Racing Car had a daily limit of 30CM, and Ricky Zhizao, Fuheng New Materials and Bai Xinglong rose more than 10%.

Organic fluorides in two underground waters in Tochigi Prefecture, Japan exceeded the standard. On the 13th, local time, it was learned that the government department of Tochigi Prefecture in Japan said on the same day that organic fluorides exceeding Japan's provisional safe range were detected in the underground waters of two wells located in Ghost Nuqiu, Zhengang City. (CCTV News)The concept of first-round economy continued to increase the daily limit of more than 10 constituent stocks, and the concept of first-round economy continued to increase in intraday trading. Media games, IP economy, performing arts and travel, and Meta-Universe all rose well. More than 10 constituent stocks such as Aofei Entertainment, Lisheng Sports, Dafeng Industry, Tianxiaxiu, and Roman shares rose by more than 10%.On the 13th, glass fell by 2.14%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract glass closed at 2505, up or down by -2.14%, with a turnover of 671,300 lots. The position data showed that the top 20 seats were clear, and the difference position was 46,081 lots. The total turnover of glass futures contracts was 999,900 lots, an increase of 189,100 lots over the previous day. The first 20 seats in the contract held 565,600 lots, a decrease of 12,000 lots from the previous day. The short positions in the top 20 seats of the contract were 661,500 lots, a decrease of 13,600 lots from the previous day. (Sina Futures)

Hongxin Electronics: Promote the technical research and development and product supply of folding mobile phone reels with Xiaomi. Hongxin Electronics officially announced today that recently, the 2024 Xiaomi Global Core Supplier Conference was held in Beijing Yanqi Lake International Convention & Exhibition Center. Under the background that Xiaomi's strategy of "people, cars and homes are all ecological" continues to deepen, Hongxin Electronics will closely follow Xiaomi's footsteps, actively expand emerging fields such as home appliances and automobiles, and provide all-round support and services in flexible electronics for Xiaomi's intelligent hardware all-ecological products. At present, in the face of the booming folding mobile phone market, Hongxin Electronics and Xiaomi jointly promote the technology research and development and product supply of folding mobile phone reels. According to reports, in the era of vigorous development of artificial intelligence and digital economy, at present, Hongxin Electronics has deeply laid out frontier fields such as AI mobile phones, AIPC, smart cars, smart homes, smart wearable devices, robots, industrial control, medical care and meta-universe.Clown won the TGA Best Indie Game Award.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.